Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

NANOMED2020 intends to bring more Nanomedicine products to European patients

16.10.2012
VDI/VDE-IT announced on 10th October a collaboration with key European Nanomedicine players which is funded by the European Commission.
This strong partnership of relevant stakeholders aims at identifying key areas for Nanomedicine research and at establishing novel concepts for translation of nanomedical innovations into clinical practice. The project called “NANOMED2020” started on 1st September 2012 and has duration of 18 months.

Making Europe a center for Nanomedicine research, development and translation is the goal of this project. To achieve this goal the proposed project unites partners already representing the largest network of active stakeholders in the Nanomedicine area as of today in Europe, embracing roughly 200 hundred Universities, Research Institutes, Hospitals and Public Health Institutions, Small and Medium-sized Enterprises (SMEs) and Small and Large Industry organizations.

What are the needs and the problems? Excellent academic research groups may need to better understand the market and the medical needs. There are a large number of pharmaceutical and medtech companies that have a comprehensive and direct access to market but these companies struggle to handle radical innovation. At the same time there is a small number of SMEs trying to add new innovation onto the market, but these few companies are too small to exploit the large potential of Nanomedicine. A consolidated pan-European approach to structure this field is therefore highly needed to bring Nanomedicine products more efficiently to patients.

“We are proud that we were able to receive funding for this project from the European Commission” said Dr. Sebastian Lange, the coordinator of this project at VDI/VDE-IT. “Seven renowned Nanomedicine players from six European countries hope to build a pertinent European Nanomedicine community involving all key players. We aim to define the resources, gaps and needs for development and implementation of Nanomedicine research into marketable innovations to be used by doctors for the benefit of patients.”

The NANOMED2020 project is an opportunity for all stakeholders from industry, academia, clinic and public authorities to provide the European Commission with input for a future Nanomedicine topic within Horizon 2020. This will make Nanomedicine an important contributor to the future European healthcare system with a beneficial impact on improved treatment for patients and on social challenges such as ageing population.

ABOUT NANOMED2020
The NANOMED2020 Support Action project, funded with a contribution of 500 000€ by the European Commission under the Work Programme FP7-HEALTH-2012 (Area 2012.4.1-5: Preparing the future for health research and innovation) was launched on 1st September 2012 and is planned to have duration of 18 months.
Partners of the NANOMED2020 project:

• ETP Nanomedicine c/o VDI/VDE-IT (Coordinator), http://www.etp-nanomedicine.eu
• CLINAM Foundation, http://www.clinam.org
• Instituto de Salud Carlos III, http://www.isciii.es
• Bioanalytik Muenster e.V., http://www.bioanalytik-muenster.de
• Nanobiotix, http://www.nanobiotix.com
• Fondazione Don Carlo Gnocchi ONLUS, http://www.dongnocchi.it
• SINTEF, http://www.sintef.no

For more information about the project consult: http://www.etp-nanomedicine.eu/public/news-events/news/start-of-nanomed-2020

The website www.nanomed2020.eu will be launched soon. Latest news on Nanomedicine research, strategic challenges and innovation concepts will be available there.

ABOUT Nanomedicine
Nanomedicine is understood to be the enabling instrument for personalized, targeted and regenerative medicine by delivering the next level of new drugs, treatments and implantable devices to clinicians and patients. Beyond that, Nanomedicine provides important new tools to deal with the grand challenge of an ageing population and is thought to be instrumental for improved and cost effective health-care, one crucial factor for making medicines and treatments available and affordable to all.

ABOUT ETP Nanomedicine c/o VDI/VDE-IT, http://www.etp-nanomedicine.eu, http://www.vdivde-it.de
VDI/VDE-IT is a leading service provider in the field of innovation and technology for customers in Germany and all over the world. We analyse, support and organise innovation and technology for clients with political, research, industry and finance backgrounds.

Since 2008, VDI/VDE-IT is managing the Office of the European Technology Platform on Nanomedicine, ETPN. This platform was established in 2005 as a joint venture of the European Commission and CEOs of large industrial companies such as Philips, Siemens and UCB, SMEs and academic research institutions to investigate and advance joint activities in the area of nanotechnology in medicine. Since 2005 the ETPN published a number of strategic documents outlining the needs and roadmaps for Nanomedicine research in Europe. The ETPN contributed to set up numerous European funded projects providing a first impression of the conditions for a suitable social and economic environment and the structural requirements for an efficient translation of R&D results into innovative Nanomedicines. The ETPN supports its members in coordinating their joint research efforts and improving communication amongst the members as well as towards the EC and the European Member States.

Press contact

NANOMED2020 Coordinator
Dr. Sebastian Lange
secretariat@etp-nanomedicine.eu
+49 30 310078 155

Wiebke Ehret | idw
Further information:
http://www.etp-nanomedicine.eu

More articles from Health and Medicine:

nachricht The cytoskeleton of neurons has been found to be involved in Alzheimer's disease
18.01.2019 | University of the Basque Country

nachricht Bioinspired nanoscale drug delivery method developed by WSU, PNNL researchers
10.01.2019 | Washington State University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ten-year anniversary of the Neumayer Station III

The scientific and political community alike stress the importance of German Antarctic research

Joint Press Release from the BMBF and AWI

The Antarctic is a frigid continent south of the Antarctic Circle, where researchers are the only inhabitants. Despite the hostile conditions, here the Alfred...

Im Focus: Ultra ultrasound to transform new tech

World first experiments on sensor that may revolutionise everything from medical devices to unmanned vehicles

The new sensor - capable of detecting vibrations of living cells - may revolutionise everything from medical devices to unmanned vehicles.

Im Focus: Flying Optical Cats for Quantum Communication

Dead and alive at the same time? Researchers at the Max Planck Institute of Quantum Optics have implemented Erwin Schrödinger’s paradoxical gedanken experiment employing an entangled atom-light state.

In 1935 Erwin Schrödinger formulated a thought experiment designed to capture the paradoxical nature of quantum physics. The crucial element of this gedanken...

Im Focus: Nanocellulose for novel implants: Ears from the 3D-printer

Cellulose obtained from wood has amazing material properties. Empa researchers are now equipping the biodegradable material with additional functionalities to produce implants for cartilage diseases using 3D printing.

It all starts with an ear. Empa researcher Michael Hausmann removes the object shaped like a human ear from the 3D printer and explains:

Im Focus: Elucidating the Atomic Mechanism of Superlubricity

The phenomenon of so-called superlubricity is known, but so far the explanation at the atomic level has been missing: for example, how does extremely low friction occur in bearings? Researchers from the Fraunhofer Institutes IWM and IWS jointly deciphered a universal mechanism of superlubricity for certain diamond-like carbon layers in combination with organic lubricants. Based on this knowledge, it is now possible to formulate design rules for supra lubricating layer-lubricant combinations. The results are presented in an article in Nature Communications, volume 10.

One of the most important prerequisites for sustainable and environmentally friendly mobility is minimizing friction. Research and industry have been dedicated...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Our digital society in 2040

16.01.2019 | Event News

11th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Aachen, 3-4 April 2019

14.01.2019 | Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

 
Latest News

Additive manufacturing reflects fundamental metallurgical principles to create materials

18.01.2019 | Materials Sciences

How molecules teeter in a laser field

18.01.2019 | Life Sciences

The cytoskeleton of neurons has been found to be involved in Alzheimer's disease

18.01.2019 | Health and Medicine

VideoLinks
Science & Research
Overview of more VideoLinks >>>